Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Prevalence of obesity in England 1980-2013
- Consequences of obesity
- Obesity costs to the NHS and society
- Assessment of the obese patient
- Goals and benefits of obesity management
- Why is it hard to lose weight and keep it off?
- Behavioural phenomena associated with adiposity
- Lifestyle weight management: core components
- Lifestyle weight management - dietary change
- Lifestyle weight management - physical activity
- Lifestyle weight management - behaviour change
- Effect of diet/exercise/behaviour change
- Finnish diabetes prevention trial (1)
- Finnish diabetes prevention trial (2)
- Look AHEAD – 4 year data
- Lifestyle: Look AHEAD study
- Very low calorie diets
- Phase 1 – weight loss
- Phase 2 – weight maintenance
- Patient pathway
- Skill mix needed for a medical obesity service
- Engagement: 12 to 24 months
Topics Covered
- Prevalence of obesity and associated disease burden
- Principals of weight management: key focus on diet, increased physical activity and behaviour change
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Wilding, J. (2015, December 31). Obesity management: lifestyle and bariatric surgery 1 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 11, 2024, from https://doi.org/10.69645/LRJQ3184.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. John Wilding, Consultant: Novo Nordisk, Orexigen; Speaker's Bureau: Novo Nordisk, Orexigen; Grant/Research Support (Principal Investigator): Novo Nordisk
Obesity management: lifestyle and bariatric surgery 1
Published on December 31, 2015
35 min
Other Talks in the Series: Obesity: Science, Medicine and Society
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name
is John Wilding.
I'm professor of medicine
at the University of Liverpool
and a consultant physician
at Aintree Hospitals
in Liverpool in the UK.
And I have an interest
in treatment of obesity,
particularly, with lifestyle
and also with bariatric surgery.
0:20
We all know that
the prevalence of obesity
has been steadily
increasing in England
as well as around the world
over the past 20 to 30 years,
as is shown in this slide here.
And although we're beginning
to see a leveling off of this,
it is now the fact that
a quarter of the population
are obese and this
results in very significant
health consequences
for the individuals concerned.
0:50
The consequences of obesity
are illustrated in this slide.
These can be broadly
thought of as those that result
in the mechanical consequences
of carrying excess body weight
and these include
problems such as joint pain,
osteoarthritis, breathlessness,
the development
of obstructive sleep apnea,
and for women
who become pregnant,
the increased risk during
childbirth is significant.
And indeed,
in the United Kingdom,
the greatest reason for maternal
mortality is in fact, obesity.
Many people also focus on
the metabolic consequences
of obesity and the number
one consequence here is,
of course, type 2 diabetes,
which is also associated
with an increased risk
of cardiovascular disease.
Non-alcoholic
fatty liver disease,
polycystic ovarian syndrome,
and infertility,
are also more
common in the obese
and it is well recognized
that many cancers,
particularly, those that
are hormone-dependent
such as breast cancer,
endometrial cancer
and prostrate cancer are
also more common in obesity.
The psychosocial consequences
for obesity include depression,
low income,
and body image dysphoria.
It's important to remember
that these
consequences of obesity
are not independent
and, in fact,
interact with each other
to create cycles of causation.
And in many obese individuals,
there are several comorbidities
present in the same individual.